BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2078316)

  • 1. Effects of calcium channel blockers on the coronary circulation.
    Cohn PF
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):299S-304S. PubMed ID: 2078316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective improvement in subendocardial perfusion distal to a flow-limiting coronary artery stenosis: effects of the new calcium channel blocking agent, FR 34235, nifedipine and diltiazem.
    Gross GJ; Warltier DC
    J Pharmacol Exp Ther; 1984 Mar; 228(3):531-6. PubMed ID: 6707908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial perfusion distal to an acute or chronic coronary artery occlusion: effects of diltiazem and nifedipine.
    Zyvoloski MG; Brooks HL; Gross GJ; Warltier DC
    J Pharmacol Exp Ther; 1982 Aug; 222(2):494-500. PubMed ID: 7097568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of calcium channel antagonist therapy on the ischemic response to acute coronary occlusion in humans.
    Kern MJ
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III77-85. PubMed ID: 2691144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of two slow channel calcium entry blockers, FR 34235 and nifedipine, on true coronary collateral blood flow.
    Gross GJ; Warltier DC; Hardman HF
    J Cardiovasc Pharmacol; 1984; 6(1):61-7. PubMed ID: 6199613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of calcium entry blockade on myocardial blood flow.
    Bache RJ
    Circulation; 1989 Dec; 80(6 Suppl):IV40-6. PubMed ID: 2557178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers.
    Altura BM; Altura BT
    Microcirc Endothelium Lymphatics; 1984 Apr; 1(2):185-220. PubMed ID: 6400430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
    Simon R
    Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of calcium entry blockers on coronary constriction and myocardial ischemia due to leukotriene D4.
    Ezra D; Boyd LM; Goldstein RE; Feuerstein G
    J Pharmacol Exp Ther; 1985 Apr; 233(1):229-34. PubMed ID: 3981457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of nifedipine on vasodilator response to acetylcholine in coronary and brachial arteries in the patients with coronary artery disease.
    Takase B; Hamabe A; Satomura K; Akima T; Uehata A; Ohsuzu F; Ishihara M; Kurita A
    Int J Cardiol; 2006 Nov; 113(3):305-10. PubMed ID: 16386809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic vasodilators in the coronary circulation.
    Schwartz JS; Bache RJ
    Circulation; 1987 Jan; 75(1 Pt 2):I162-7. PubMed ID: 3791617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)].
    Nakaya H
    Hokkaido Igaku Zasshi; 1981 May; 56(3):335-45. PubMed ID: 7319455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium-channel blockers for combined systemic hypertension and myocardial ischemia.
    Frishman WH; Charlap S
    Circulation; 1987 Jun; 75(6 Pt 2):V154-62. PubMed ID: 3552312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel modulation: ability to inhibit or promote calcium influx resides in the same dihydropyridine molecule.
    Thomas G; Gross R; Schramm M
    J Cardiovasc Pharmacol; 1984; 6(6):1170-6. PubMed ID: 6084776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin receptor blocker improves coronary flow velocity reserve in hypertensive patients: comparison with calcium channel blocker.
    Kamezaki F; Tasaki H; Yamashita K; Shibata K; Hirakawa N; Tsutsui M; Kouzuma R; Nagatomo T; Adachi T; Otsuji Y
    Hypertens Res; 2007 Aug; 30(8):699-706. PubMed ID: 17917317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of nitrates, nitrate-like substances, calcium antagonists and beta-adrenergic receptor blockers on peripheral circulation].
    Busse R; Bassenge E
    Herz; 1982 Dec; 7(6):388-405. PubMed ID: 6131027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.